MoonLake Immunotherapeutics: Form 8-K, filed Feb 25, 2022
Filed with the SEC on Feb 25, 2022 and accepted by EDGAR at Feb 25, 2022, 16:27 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-22-009481. Last ingested by Listed: Nov 4, 2026, 07:34 ET. Listed shows no prices and gives no investment advice.